Friday, December 19, 2014 11:17:27 PM
the years that strange things happen during the holidays.
The 2 big trades may be some sort of book squaring thing
between two brokers. This has a name, is it a cab trade?
They could be real trades. I don't know.
It's nice to see the price move up a little.
Checking,
http://shortvolume.com/
all week, the shorts were more than half the volume,
a couple of days.
And at,
http://www.nasdaq.com/symbol/onvo/short-interest
the last report had nearly 18 million short interest.
This seems like a lot to me. And it looks like it will
increase for the next report on the 24th. We'll see.
I would like to see a short covering rally some day.
I don't recall ever witnessing this in a stock, especially
one with this many shorts.
Last 25 Trades
Time Price Shares Change Exch/Mkt
12/19/2014 7:57 PM EST T 7.13 500 0.39 NDD
12/19/2014 7:49 PM EST T 7.13 2,000 0.39 EDGX
12/19/2014 7:48 PM EST T 7.13 1,000 0.39 NDD
12/19/2014 7:41 PM EST T 7.13 380 0.39 NDD
12/19/2014 7:07 PM EST T 7.13 500 0.39 NDD
12/19/2014 5:47 PM EST T 7.13 500 0.39 NDD
12/19/2014 5:30 PM EST T 7.13 2,000 0.39 NDD
12/19/2014 5:27 PM EST T 7.12 882 0.38 NDD
12/19/2014 5:27 PM EST T 7.12 1,118 0.38 NDD
12/19/2014 5:04 PM EST T 7.13 500 0.39 NDD
12/19/2014 5:02 PM EST I 7.13 69 0.39 EDGX
12/19/2014 4:59 PM EST B 7.239 447,986 0.50 NDD
12/19/2014 4:59 PM EST B 7.239 23,414 0.50 NDD
12/19/2014 4:48 PM EST B 7.24 8,550 0.50 NDD
12/19/2014 4:25 PM EST P 7.24 3,994 0.50 NDD
12/19/2014 4:24 PM EST T 7.13 1,000 0.39 NDD
12/19/2014 4:23 PM EST T 7.13 1,000 0.39 EDGX
12/19/2014 4:23 PM EST T 7.13 1,000 0.39 EDGX
12/19/2014 4:17 PM EST T 7.13 500 0.39 NDD
12/19/2014 4:04 PM EST I 7.24 24 0.50 NDD
12/19/2014 4:03 PM EST 6 7.24 701,975 0.50 AMX
12/19/2014 4:01 PM EST T 6.90 7,200 0.16 NDD
12/19/2014 4:00 PM EST I 7.12 52 0.38 NDD
12/19/2014 4:00 PM EST X 6.90 17,800 0.16 NSD
12/19/2014 3:59 PM EST I 7.08 4 0.34 AMX
Recent ONVO News
- Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo • GlobeNewswire Inc. • 04/15/2024 12:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/09/2024 05:15:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/08/2024 09:56:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:05:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/26/2024 10:09:03 PM
- Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress • GlobeNewswire Inc. • 01/25/2024 01:05:00 PM
- Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress • GlobeNewswire Inc. • 01/09/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:05:09 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/22/2023 11:05:02 AM
- Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results • GlobeNewswire Inc. • 12/06/2023 01:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/01/2023 09:07:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 11:41:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 11:40:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 11:37:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 11:34:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 11:32:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/15/2023 09:41:04 PM
- CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan • GlobeNewswire Inc. • 11/13/2023 01:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:10:34 PM
- Organovo Highlights FXR314 Combination Therapy Potential and Plan • GlobeNewswire Inc. • 11/08/2023 01:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 12:05:08 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 08:05:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/13/2023 09:06:56 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM